SCHEMBL8957396

SCHEMBL8957396

O=[N+]([O-])OCCCc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.52
LMNA P02545 1/20 0.49
CYP19A1 P11511 1/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
FFAR1 O14842 1/20 0.44
NPC1 O15118 1/20 0.44
RECQL P46063 1/20 0.44
RAB9A P51151 1/20 0.44
ESR2 Q92731 2/20 0.43
HDAC3 O15379 2/20 0.43
HDAC4 P56524 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6752122 0.94 IDO1 (0.46) IDO1LMNAFFAR1ESR2CA12
SCHEMBL600669 0.93 CA12 (0.46) IDO1FFAR1ESR2CA12CA1
SCHEMBL17966112 0.93 CA12 (0.46) IDO1FFAR1ESR2CA12CA1
SCHEMBL17966102 0.93 CA12 (0.46) IDO1FFAR1ESR2CA12CA1
SCHEMBL7591237 0.93 CA12 (0.46) IDO1FFAR1ESR2CA12CA1
SCHEMBL1491311 0.88 CA1 (0.46) IDO1CYP19A1CYP11B1CYP11B2FFAR1
SCHEMBL8957375 0.81 ESR1 (0.45) LMNAESR2CA12CA1CA2
SCHEMBL10595320 0.81 POLB (0.46) CYP19A1CYP11B1CYP11B2NPC1CA12
SCHEMBL3025585 0.81 RARB (0.49) ESR2CA12CA1CA2CA4
SCHEMBL8957360 0.79 CALM1 (0.50) NPC1RAB9ACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107412781-A Self assembly drug-loading system of ortho-nitrophenyl propionic acid taxol conjugate and its preparation method and application 北京大学 2017-12-01 CN claimed
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed
CN-107412781-A Self assembly drug-loading system of ortho-nitrophenyl propionic acid taxol conjugate and its preparation method and application 北京大学 2017-12-01 CN disclosed
CN-102584801-A One-pot asymmetric synthesis process of HIV reverse transcriptase inhibitor efavirenz compounds SHANGHAI INST ORGANIC CHEM 2012-07-18 CN disclosed
CN-1331601-C Method of Chiral alkamine ligand used as catalyst of asymmetric addition process for terminal alkyne to fluoroalkylaryl ketone SHANGHAI INST ORGANIC CHEM (CN) 2007-08-15 CN disclosed
CN-1216036-C Chiral alkamine ligand and its application in asymmetrical addition of terminal alkyne para imine SHANGHAI INST ORGANIC CHEM (CN) 2005-08-24 CN disclosed
CN-1449865-A Method of Chiral alkamine ligand used as catalyst of asymmetric addition process for terminal alkyne to fluoroalkylaryl ketone SHANGHAI INST ORGANIC CHEM (CN) 2003-10-22 CN disclosed
CN-1442403-A Chiral alkamine ligand and its application in asymmetrical addition of terminal alkyne para imine SHANGHAI INST ORGANIC CHEM (CN) 2003-09-17 CN disclosed
CN-1029684-C Process for preparing dynophine derivative EISAI CO LTD (JP) 1995-09-06 CN disclosed
US-5049694-A Cardiovascular disorders CEDONA PHARMACEUTICALS B.V. (NL) 1991-09-17 US disclosed
EP-0359335-A2 Pharmaceutical composition having relaxing activity which contains a nitrate ester as active substance CEDONA PHARMACEUTICALS B.V. (NL) 1990-03-21 EP disclosed
CN-85109722-A Process for producing Dinorfene (DYNOPHINE) derivatives 1986-10-08 CN disclosed